Mouse anti Rabies Virus antibody, clone Rab-50 recognizes rabies virus and shows conformation dependent specificity for the viral envelope glycoprotein. Mouse anti Rabies Virus antibody, clone Rab-50 is not known to react with any other organism.
- Target Species
- Product Form
- Ig fraction - liquid
- Ammonium Sulphate fractionation
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- Carrier Free
- Purified virions of SAD-Vnukovo strain followed by Pitman-Moore strain.
- Approx. Protein Concentrations
- 1.0 mg/ml
- Fusion Partners
- Spleen cells from immunised Balb/c female mice were fused with cells of the NS0 myeloma cell line.
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- 18 months from date of despatch.
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of Rabies Virus antibody
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
References for Rabies Virus antibody
Máciková, I. et al. (1992) Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
Acta Virol. 36 (6): 541-50.
Li, C. et al. (2011) Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus.
Acta Pharmacol Sin. 32: 329-37.